Mirtazapine to alleviate severe breathlessness in patients with COPD or interstitial lung diseases (BETTER-B): an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trial

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00187-5/fulltext?dgcid=hubspot_email_conferencealerts_ers24&utm_campaign=conferencealerts&utm_medium=email&_hsenc=p2ANqtz--WSZFiZgXRJiUHt5L_NrmS2YkcUGGO-CMvadSv5KZPiF51340szI__4qTo_RrSkzOgQvMot84Xef5mlTjGpjmpxRIanw&_hsmi=325072833&utm_content=323935440&utm_source=hs_email